Affordable Access

Publisher Website

Glutamine in the critically ill patient: can it affect mortality?

Authors
Journal
Clinical Nutrition Supplements
1744-1161
Publisher
Elsevier
Publication Date
Volume
1
Issue
1
Identifiers
DOI: 10.1016/j.clnu.2004.07.007

Abstract

Summary The survival of an intensive care patient is in part related to how well they can defend themselves against the damaging inflammatory processes and how well they can heal and recover. Simply blocking inflammatory mediators has, not surprisingly, proved relatively ineffective. However, a nutrient deficiency of glutamine can occur and compromises many important cellular protective, immune and recovery processes that may influence a patient's survival. This brief review discusses the evidence suggesting that an additional exogenous supply of glutamine is needed and why the systemic delivery of glutamine via the parenteral route has been shown in clinical studies to improve long-term survival.

There are no comments yet on this publication. Be the first to share your thoughts.